Fractyl Health, Inc Common Stock (GUTS) had the highest return between February 1, 2024 and May 1, 2024 by a US stock, returning 11,485,614.3%.
| ASSET | DATE | % RETURN |
|---|---|---|
Fractyl Health, Inc Common Stock (GUTS) | 2/1/2024 - 5/1/2024 | 11,485,614.29% |
Root (ROOT) | 2/1/2024 - 5/1/2024 | 749.45% |
Janux Therapeutics (JANX) | 2/1/2024 - 5/1/2024 | 568.85% |
AI Financial (AIFC) | 2/1/2024 - 5/1/2024 | 522.81% |
Candel Therapeutics (CADL) | 2/1/2024 - 5/1/2024 | 491.11% |
GeneDx (WGS) | 2/1/2024 - 5/1/2024 | 443.38% |
Nexalin Technology (NXL) | 2/1/2024 - 5/1/2024 | 405.99% |
Mobile-health Network Solutions Class A Ordinary Shares (MNDR) | 2/1/2024 - 5/1/2024 | 347.39% |
Airship AI (AISP) | 2/1/2024 - 5/1/2024 | 342.86% |
Mediaco (MDIA) | 2/1/2024 - 5/1/2024 | 340.11% |
Datasea (DTSS) | 2/1/2024 - 5/1/2024 | 327.37% |
Im Cannabis (IMCC) | 2/1/2024 - 5/1/2024 | 308.54% |
Mesoblast (MESO) | 2/1/2024 - 5/1/2024 | 305.06% |
Envoy Medical (COCH) | 2/1/2024 - 5/1/2024 | 260.16% |
Sonida Senior Living (SNDA) | 2/1/2024 - 5/1/2024 | 256.91% |
vTv Therapeutics (VTVT) | 2/1/2024 - 5/1/2024 | 246.47% |
Avalo Therapeutics (AVTX) | 2/1/2024 - 5/1/2024 | 244.09% |
Niki BioSolutions (NIKI) | 2/1/2024 - 5/1/2024 | 239.72% |
CytomX Therapeutics (CTMX) | 2/1/2024 - 5/1/2024 | 235.29% |
Skye Bioscience, Inc Common Stock (SKYE) | 2/1/2024 - 5/1/2024 | 215.8% |
Viking Therapeutics (VKTX) | 2/1/2024 - 5/1/2024 | 214.53% |
Nektar Therapeutics (NKTR) | 2/1/2024 - 5/1/2024 | 200% |
XTL Biopharmaceuticals Ltd ADR (XTLB) | 2/1/2024 - 5/1/2024 | 196.8% |
Veru (VERU) | 2/1/2024 - 5/1/2024 | 196.22% |
Climb Bio (CLYM) | 2/1/2024 - 5/1/2024 | 195.7% |